Khiron Life Sciences Corp.
KHRNH.V
TSX
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.41M | 4.52M | 4.11M | 7.05M | 12.20M |
| Total Receivables | 3.31M | 3.41M | 3.50M | 2.28M | 3.23M |
| Inventory | 7.15M | 7.32M | 7.70M | 7.47M | 7.86M |
| Prepaid Expenses | 1.48M | 1.51M | 2.19M | 1.99M | 2.18M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.35M | 16.76M | 17.49M | 18.79M | 25.46M |
|
|
|||||
| Total Current Assets | 13.35M | 16.76M | 17.49M | 18.79M | 25.46M |
| Net Property, Plant & Equipment | 9.57M | 10.63M | 11.87M | 10.71M | 12.37M |
| Long-term Investments | 4.45M | 3.16M | 3.44M | 3.22M | 2.92M |
| Goodwill | 4.45M | 3.16M | 3.44M | 3.22M | 2.92M |
| Total Other Intangibles | 631.50K | 689.40K | 722.50K | 685.90K | 11.77M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 28.01M | 31.24M | 33.52M | 33.41M | 52.53M |
|
|
|||||
| Total Accounts Payable | 4.92M | 5.13M | 5.15M | 3.40M | 4.57M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 893.00K | 663.00K | 1.63M | 1.20M | 583.60K |
| Total Finance Division Other Current Liabilities | 785.90K | 121.90K | 104.90K | 1.49M | -- |
| Total Other Current Liabilities | 785.90K | 121.90K | 104.90K | 1.49M | -- |
| Total Current Liabilities | 6.60M | 5.92M | 6.89M | 6.10M | 5.15M |
|
|
|||||
| Total Current Liabilities | 6.60M | 5.92M | 6.89M | 6.10M | 5.15M |
| Long-Term Debt | 254.90K | 315.20K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 719.60K | 840.80K | 603.10K | 557.10K | 946.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 691.20K | 974.30K | 2.39M | 413.30K | 2.92M |
| Total Liabilities | 8.27M | 8.05M | 9.88M | 7.07M | 9.02M |
|
|
|||||
| Common Stock & APIC | 110.61M | 116.76M | 117.45M | 115.73M | 115.73M |
| Retained Earnings | -93.21M | -96.58M | -97.90M | -92.31M | -76.96M |
| Treasury Stock & Other | 2.34M | 3.01M | 4.09M | 2.92M | 4.73M |
| Total Common Equity | 19.74M | 23.19M | 23.64M | 26.34M | 43.50M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.74M | 23.19M | 23.64M | 26.34M | 43.50M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.74M | 23.19M | 23.64M | 26.34M | 43.50M |
|
|
|||||
